Fusaric acid in Parkinson's disease.
D000368:Aged; D000978:Antiparkinson Agents; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000503:physiopathology; D010848:Picolinic Acids / Q000627:therapeutic use*; D011339:Probenecid
D000978:Antiparkinson Agents; D010848:Picolinic Acids; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid; D006719:Homovanillic Acid